Lv5
1240 积分 2021-06-08 加入
Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion–Positive Lung Cancer by Combining Selpercatinib with Crizotinib
6天前
已完结
CD8αα and CD8αβ: truly different?
6天前
已完结
Anti-PD-L1 × anti-CD3 bispecific T-cell engager-armed T cells can overcome immunosuppression and redirect T cells to kill breast cancer cells expressing PD-L1
6天前
已完结
A PD-L1/CD3 BISPECIFIC ANTIBODY ENHANCES THE ANTI-TUMOR EFFECTS OF REGORAFENIB AGAINST COLON CANCER
6天前
已完结
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
8天前
已完结
From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials
8天前
已完结
Lipopolysaccharide Induces Resistance to CAR-T Cell Therapy of Colorectal Cancer Cells through TGF-β-Mediated Stemness Enhancement
24天前
已完结
From Concept to Cure: The Evolution of CAR-T Cell Therapy
1个月前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
1个月前
已完结
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-Type Non-Small Cell Lung Cancer
1个月前
已完结
皖公网安备34019202002308
